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Abstract The e¡ect of triiodothyronine (T3) on mitochondrial
e⁄ciency could be related to an increase in the concentrations of
some proteins, such as uncoupling proteins (UCPs). Free fatty
acids (FFA) seem to be a cofactor essential for the uncoupling
activity of UCP3. In this paper, we report that the hypothyroid-
ism^hyperthyroidism transition is accompanied by increases: (i)
in the endogenous levels of mitochondrial FFA and (ii) in the
sensitivity to FFA shown by the mitochondrial respiration rate
and membrane potential, which correlated with the level of
UCP3 protein. The level of the mRNA for adenine-nucleotide
translocase-1 (ANT) was not a¡ected by the thyroid state, while
the ANT contribution to FFA-induced changes in mitochondrial
uncoupling was low in the hypothyroid and euthyroid states but
became more relevant in the hyperthyroid state at the highest
concentration of FFA.
* 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The idea that triiodothyronine (T3) is able to change mito-
chondrial e⁄ciency can be traced back to the studies by Lardy
and Feldcott in the early 1950s. They showed that the addi-
tion of thyroxine to isolated mitochondria in vitro led to a
reduction in the respiratory control ratio (RCR) [1]. On the
basis of such data, they suggested that the major cellular
mechanism underlying the calorigenic e¡ect of thyroid hor-
mones might be an uncoupling of oxidative phosphorylation.
This hypothesis was subsequently discarded as not really
physiologically relevant. Recently, however, new results have
led to revival of interest in the ‘uncoupling hypothesis’ as
applied to thyroid hormones. It has been shown that: (i)
hyperthyroidism is associated with an increased leak of pro-
tons through the inner mitochondrial membrane, whereas the
opposite occurs in hypothyroid mitochondria [2] and (ii) that
uncoupling proteins (UCPs) are present in almost all tissues,
not just in brown adipose tissue. Several ¢ndings pointed
strongly towards a role for UCP3 in the mechanisms under-
lying T3-dependent energy expenditure, namely: (i) UCP3 is
almost exclusively present in skeletal muscle [3], (ii) the skel-
etal-muscle proton leak accounts for a signi¢cant fraction of
the resting metabolic rate in the whole animal [4], (iii) mice
overexpressing UCP3 are hyperphagic and lean, with a de-
creased mitochondrial e⁄ciency [5], and (iv) in skeletal muscle
and heart, T3 is able to increase the UCP3 mRNA [6^8] and
protein [9,10] levels.
Recently, we showed that the expression of UCP3 mRNA
in skeletal muscle increases during the hypothyroidism^hyper-
thyroidism transition and that mitochondria isolated from the
skeletal muscle of euthyroid and hyperthyroid rats show a
proton leak higher than that of their hypothyroid counter-
parts [8]. The latter result has been con¢rmed by Jucker et
al. [10] who, while assessing mitochondrial energy coupling in
skeletal muscle in vivo by a non-invasive method (nuclear
magnetic resonance spectroscopy), found that injection of
T3 into hypothyroid rats led to mitochondrial uncoupling in
skeletal muscle. More recently, by time-course studies, we
have shown that UCP3 has the potential to be a molecular
determinant in the regulation of resting metabolic rate by
thyroid hormone [9].
In the above study on rat skeletal muscle mitochondria [8],
the changes in proton-leak kinetics that accompanied the hy-
pothyroidism^hyperthyroidism transition disappeared when
fatty-acid-free bovine serum albumin (BSA) was included in
the incubation medium. An explanation for these results could
be that the di¡erence in proton leak between the hypo- and
hyperthyroid states is related to a di¡erence in the endogenous
content of mitochondrial free fatty acids (FFA) capable of
a¡ecting uncoupled respiration, and that BSA, by chelating
FFA, abolished their e¡ect. However, the same results could
also be explained on the basis of a crucial involvement of
FFA as cofactors for UCP3-uncoupling activity. The latter
hypothesis seems to be supported by the recent ¢ndings of
Echtay et al., who found FFA to be important cofactors for
the activation by coenzyme Q (CoQ) of UCP2 and UCP3
(expressed in Escherichia coli), and by the more recent ones
of Echtay and Brand, who found CoQ, FFA and reactive
oxygen species (ROS) to be involved in the variations in the
UCP-mediated proton leak [11,12]. Because of this, it seemed
important to study the di¡erences in endogenous mitochon-
drial FFA levels among di¡erent thyroid states and also the
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sensitivity to FFA shown by the mitochondrial respiration
rate (Jo) and membrane potential (mp). In the present study,
we measured the endogenous FFA content in skeletal muscle
mitochondria from animals in di¡erent thyroid states, as well
as the sensitivity shown by Jo and mp to exogenous FFA.
Knowing that in the liver, T3 is able to a¡ect ANT (ad-
enine-nucleotide translocase, a carrier sensitive to FFA and
able to uncouple mitochondria) we also evaluated the contri-
bution made by ANT to the T3-induced changes in the above
parameters in skeletal muscle.
2. Materials and methods
2.1. Materials
T3 was purchased from Sigma-Aldrich Corp. (St. Louis, MO,
USA). A polyclonal antibody raised against the C-terminal region
of the human UCP3 protein (AB3046) was purchased from Chemicon
International (Temecula, CA, USA).
2.2. Animal treatment
All animal studies were conducted in accordance with the National
Guide for the Care and Use of Laboratory Animals. Three di¡erent
groups of Male Wistar rats (250^300 g) were used throughout: hypo-
thyroid, euthyroid and hyperthyroid groups.
Hypothyroidism was induced by the i.p. administration of propyl-
thiouracil (1 mg/100 g bw) for 4 weeks together with a weekly i.p.
injection of iopanoic acid (6 mg/100 g bw). Hyperthyroidism was
induced by the daily i.p. administration of T3 (15 Wg/100 g bw) for
1 week.
In the euthyroid group, the rats were injected with saline.
2.3. Isolation of mitochondria
Mitochondria from gastrocnemius and tibialis anterior muscles
were isolated after homogenization in an incubation medium consist-
ing of 220 mM mannitol, 70 mM sucrose, 20 mM Tris^HCl, 1 mM
EDTA and 5 mM EGTA, pH 7.4. After homogenization, each sample
was centrifuged at 700Ug, with the resulting supernatant being cen-
trifuged at 8000Ug. The mitochondrial pellet was washed twice, re-
suspended in a minimal volume and kept on ice.
2.4. Western blot analysis
Analyses were performed using mitochondria suspended in isolation
medium supplemented with the following protease inhibitors: 1 mM
benzamidine, 4 Wg/ml aprotinin, 1 Wg/ml pepstatin, 2 Wg/ml leupeptin,
5 Wg/ml betastatin, 50 Wg/ml N-tosyl-L-phenylalanine-chloromethyl ke-
tone and 0.1 mM phenylmethylsulfonyl£uoride (all from Sigma-Al-
drich Corp.).
Mitochondrial lysate was prepared by resuspending the mitochon-
dria in sodium dodecyl sulfate (SDS) loading bu¡er, as described by
Laemmli [13], followed by heating for 3 min at 95‡C. Mitochondrial
lysates containing 30 Wg protein were loaded in each lane and elec-
trophoresed on a 13% SDS^PAGE (polyacrylamide gel electrophore-
sis) gel. A polyclonal antibody against UCP3 and an anti-rabbit anti-
body were used as primary and secondary antibodies, respectively, on
duplicate ¢lters in a chemiluminescence protein-detection method
based on a protocol from a commercially available kit (NEN, Boston,
MA, USA). The protein concentration was determined by the method
of Hartree [14]. UCP3 protein levels were determined and quanti¢ed
in separate preparations from three rats.
2.5. Determination of respiration rate
Respiratory parameters were determined using a Clark-type oxygen
electrode. They were measured in a mitochondrial suspension (0.5 mg/
ml) at 37‡C in standard incubation medium A [80 mM KCl/50 mM
HEPES (pH 7)/1 mM EGTA/5 mM K2HPO4/5 mM MgCl2] both in
the presence and in the absence of 1% (w/v) BSA, using a saturating
amount of succinate as substrate (5 mM). State 3 respiration was
initiated by the addition of ADP (200 WM).
2.6. Evaluation of mitochondrial FFA content in di¡erent thyroid states
Mitochondria (0.1^0.15 mg) were incubated in 1 ml of standard
incubation medium A. The respiration in the presence of endogenous
FFA (State 43BSA) was initiated by energizing mitochondria with
succinate and subsequently inhibited by the addition of 1% BSA
(State 4þBSA). At this concentration, BSA is the predominant protein
and FFA can therefore be considered to be bu¡ered by the albumin.
State 4þBSA was successively stimulated by adding increasing amounts
of oleate. We chose oleate since the binding-a⁄nity constant of BSA
for oleate is known and, by using the equation of Richieri et al. [15], it
is possible to estimate the real amount of oleate that is not bound to
BSA, and therefore free to interact with mitochondria (free oleate).
For each mitochondrial preparation we determined the amount of
free oleate that, when added to mitochondria respiring in State 4þBSA;
was able to restore the value of State 43BSA ; we used this value as an
index of the mitochondrial FFA content. Although this method does
not give a real value for mitochondrial endogenous FFA content, it is
useful for the present study because: (i) it gives an indication of the
levels of FFA able to a¡ect State 4 respiration and (ii) our aim was to
estimate the change occurring in the level of FFA during the hypo-
thyroidism^hyperthyroidism transition.
In the approach we used, we assumed that in each mitochondrial
preparation, the endogenous pool of fatty acid behaves as oleate in
stimulating respiration.
2.7. Measurement of proton-motive force
Proton-motive force is the sum of membrane potential (mp) and the
Hþ gradient across the mitochondrial membrane. To simplify mea-
surements, the pH gradient was abolished by the addition of nigericin
so that mitochondria increase mp to compensate and the whole of the
proton-motive force was expressed as v8. The magnitude of mp was
determined from the distribution of the lipophilic cation triphenyl-
methylphosphonium (Ph3MePþ), which was measured using a
Ph3MePþ-sensitive electrode, as described by Brown and Brand [16].
A Ph3MePþ-binding correction of 0.4 was applied for mitochondria
from each group.
2.8. E¡ect of oleate on mitochondria
The responses shown by mitochondrial membrane potential and
respiration rate to oleate were measured simultaneously in standard
incubation medium A supplemented with 1% BSA, nigericin (80 ng/
ml) and oligomycin (1 WM), measurement being made in the presence
and in the absence of carboxyatractiloside (15 Wg/ml). The presence of
EGTA in the incubation medium allowed us to exclude the eventual
opening of permeability transition pores. Respiration was initiated by
the addition of succinate to the mitochondrial suspension and then
stimulated by increasing the concentration of oleate (¢nal concentra-
tions 0.25, 0.5 and 0.75 mM, corresponding to calculated free concen-
trations of 11, 33 and 172 nM, respectively). For the measurements
described, oleate was dissolved in 50% ethanol; the ethanol did not in
itself have any e¡ect on the parameters measured and so is repre-
sented herein as a zero concentration of oleate.
2.9. Statistical analysis
The statistical signi¢cance of di¡erences between groups was deter-
mined by use of a one-way analysis of variance followed by a Stu-
dent^Newman^Keuls test.
3. Results
3.1. Respiratory parameters for skeletal muscle mitochondria
from euthyroid, hypothyroid and hyperthyroid rats
Table 1 shows the e¡ect of thyroid state on mitochondrial
respiratory parameters determined in the presence and in the
absence of BSA. In the presence of BSA, the values obtained
for States 4 and 3 were signi¢cantly higher for euthyroid and
hyperthyroid mitochondria than for the hypothyroid ones. As
the percentage increases during the hypothyroid^hyperthyroid
transition were similar for States 3 and 4, the RCR value
remained unchanged.
The State 4 respiration rate was higher in euthyroid mito-
chondria than in hypothyroid mitochondria by a similar per-
centage whether measured in the absence or presence of BSA
(29% and 27%, respectively). However, the corresponding val-
ue for hyperthyroid versus hypothyroid mitochondria di¡ered
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markedly between the absence of BSA (49%) and its presence
(20%).
The above results could mean that hyperthyroid mitochon-
dria have a higher FFA content and/or that hyperthyroidism
makes mitochondria more sensitive to FFA.
To try to distinguish between these possibilities, we deter-
mined the mitochondrial endogenous FFA concentration that
was responsible for the observed di¡erences between the State
4 respiration rates measured in the absence and presence of
BSA. To this end, we determined the amount of oleate that,
when progressively added to mitochondria respiring in State 4
in the presence of BSA, was able to restore the respiration rate
to the value observed in the absence of BSA. On this basis,
our data (Table 1) show that the FFA content of euthyroid
mitochondria was 34% higher than that of hypothyroid ones,
while that of hyperthyroid mitochondria was 95% and 162%
higher than that of euthyroid and hypothyroid mitochondria,
respectively.
3.2. E¡ect of increasing the concentration of oleate on
respiration rate and membrane potential in skeletal muscle
mitochondria from hypothyroid, euthyroid and
hyperthyroid rats
Fig. 1 illustrates the e¡ect of oleate on respiration rate and
Table 1
Respiration rates for skeletal muscle mitochondria from hypothyroid, euthyroid and hyperthyroid rats
Hypothyroid Euthyroid Hyperthyroid
State 4þBSA 92.3S 9.8 117.5S 6.4* 111.3S 3.8*
State 3þBSA 378.4S 20 470S 15* 480S18*
RCR 4.1S 0.2 4.0S 0.3 4.3 S 0.3
State 43BSA 225.4S 18.3 292.2S 17.8* 336.7S 25.8*
Endogenous FFA concentration (nM) 23.2S 3.6 31.2S 3.3* 60.8S 13.4*‡
Calculated respiration rates (nA oxygen/(min mg proteins)) are for incubation with BSA either present in the incubation medium (State 4þBSA
and State 3þBSA) or absent from it (State 43BSA). Values represent the meanSS.E. from ¢ve di¡erent experiments.
*P6 0.05 vs. hypothyroid state, ‡P6 0.05 vs. euthyroid state.
Fig. 1. E¡ects of oleate titration on respiration rate (panels A and C) and membrane potential (panels B and D) in skeletal muscle mitochon-
dria isolated from hypothyroid, euthyroid and hyperthyroid rats. Panels C and D depict titrations performed in the presence of carboxyatracti-
loside (15 Wg/ml), panels A and B those performed in its absence. The concentrations of oleate shown represent those which are not bound to
BSA and are therefore able to interact with mitochondria. Each value represents the meanSS.E. from four di¡erent mitochondrial prepara-
tions.
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membrane potential in skeletal muscle mitochondria in di¡er-
ent thyroid states when measured in the absence (panels A
and B) or presence (panels C and D) of carboxyatractiloside
(CAT), a speci¢c inhibitor of ANT activity. In each thyroid
state, oleate induced simultaneously an increase in the oligo-
mycin-inhibited respiration rate and a decrease in membrane
potential (which is diagnostic of mitochondrial uncoupling).
However, the FFA sensitivity of mitochondria increased in
the order hypothyroid^euthyroid^hyperthyroid state. Hypo-
thyroid mitochondria showed the lowest respiration rate and
the highest membrane potential, while the opposite was true
for hyperthyroid mitochondria (see Fig. 1). Over the range of
oleate concentrations we used (0^172 nM free oleate), the
slope of the curves relating membrane potential to the free
oleate concentration increased in the order hypothyroid^eu-
thyroid^hyperthyroid both in the presence (panel D) and in
the absence of CAT (panel B). The involvement of ANT in
the e¡ect of oleate on mitochondrial respiration and mem-
brane potential seemed to be low (compare panels C and D
with A and B), the only noteworthy e¡ect of ANT inhibition
being seen on membrane potential in the hyperthyroid state
and then only in the presence of the highest concentration of
FFA. To be speci¢c, we found 172 nM oleate induced a de-
crease in membrane potential of about 3%, 6% and 53% in
hypothyroid, euthyroid and hyperthyroid mitochondria, re-
spectively (panel B). When the ANT contribution was ex-
cluded, the decrease in membrane potential was found to be
4%, 6% and 33% for hypothyroid, euthyroid, and hyperthy-
roid mitochondria (panel D).
3.3. UCP3 mitochondrial protein content and ANT1 mRNA
levels
Fig. 2 shows the results of Western blot analysis of the
UCP3 content of skeletal muscle mitochondria. Quanti¢cation
revealed that in hyperthyroid mitochondria, the UCP3 level
was about 3.5 times that seen in the euthyroid state and seven
times that in the hypothyroid state.
In addition, skeletal muscle ANT1 mRNA was evaluated in
hypothyroid, euthyroid and hyperthyroid rats by reverse-tran-
scription (RT)-PCR, but its level was found not to be in£u-
enced by the thyroid state (data not shown).
4. Discussion
Mitochondrial respiration is not fully coupled to ADP
phosphorylation and some of the energy of the reduced sub-
strate is lost as heat. Most of the uncoupling is due to a leak
of protons across the mitochondrial inner membrane, the ma-
jor process controlling mitochondrial oxygen consumption
when cellular ATP requirements are low. This non-productive
proton-conductance pathway is physiologically relevant, as it
accounts for a signi¢cant portion of cellular metabolic rate at
rest [4].
Thyroid hormone a¡ects mitochondrial e⁄ciency, and
UCP3 could mediate this e¡ect. As FFA seem to be important
cofactors for UCP3 activity, it was important to estimate the
changes in FFA content and/or sensitivity associated with
alterations in thyroid state.
During the hypothyroidism^hyperthyroidism transition we
showed: (i) an increase in State 4 respiration (a state of res-
piration controlled principally by proton-leak reactions [17])
that showed a high correlation with the increase in UCP3
protein levels only when FFA were present (r=0.8), (ii) a
progressive increase in the endogenous mitochondrial content
of FFA able to a¡ect uncoupled respiration that correlates
strictly with the increase in UCP3 protein level (r=0.998),
and (iii) a progressive increase in the uncoupling e¡ect of
oleate (as evaluated by measuring the increase in respiration
rate that occurred concomitant with a decrease in membrane
potential) that was associated with an increase in the UCP3
level.
The data we obtained showing a higher FFA content in
hyperthyroid mitochondria and a higher sensitivity of such
mitochondria to added FFA are in accord with data pub-
lished by Simonyan et al. [18], who obtained similar results
in a di¡erent physiological situation (when the UCP3 level
increased due to a cold exposure). In these conditions, in
fact, they reported an increased recoupling e¡ect of BSA
and a higher sensitivity of skeletal muscle mitochondria to
the added FFA. They observed similar e¡ects after an in
vivo injection of thyroxine.
ANT is a mitochondrial carrier able to mediate fatty-acid-
induced uncoupling by carrying deprotonated FFA from the
matrix to the intermembrane space, as ¢rst proposed by Sku-
lachev [19]. Its activity could a¡ect the estimation of the
amount of FFA-mediated uncoupling attributed to UCP3,
leading to possible errors. In rats, two isoforms of ANT are
expressed in a tissue-speci¢c manner (the muscle-speci¢c form
ANT1 and the ubiquitous form ANT2) [20]. In rat liver,
ANT2 is the main isoform and its expression is regulated by
T3 [21,22]. By contrast, ANT1 is not responsive to thyroid
hormones since injection of T3 into hypothyroid rats does not
a¡ect the ANT1 mRNA level. The involvement of the ANT
antiporter in thyroid-hormone-induced uncoupling has been
demonstrated by Sho«nfeld et al. [23] in mitochondria from
rat liver, a tissue lacking UCPs (with the exception of Kup¡er
cells, which express UCP2 [24]). They reported a two-fold
increase in mitochondrial ANT content and an almost four-
fold increase in its activity after the administration of T3 to
hypothyroid rats, suggesting that mitochondrial enrichment
with ANT protein does not account for all of the increased
activity. Other factors, such as the mitochondrial lipid envi-
ronment or ATP-ADP pool, both of which are in£uenced by
the thyroid state [23,25], can a¡ect both ANT activity and
Fig. 2. UCP3 level in skeletal muscle mitochondria isolated from eu-
thyroid (N), hypothyroid (P+I) and hyperthyroid (N+T3) animals.
The upper panel shows Western immunoblot analysis. The lower
panel, quanti¢cation of the data shown in the upper panel. Data
are relative to the value for control (N) muscle (taken as 100).
*P6 0.05 vs. hypothyroid state, ‡P6 0.05 vs. euthyroid state.
FEBS 26796 19-11-02
A. Lombardi et al./FEBS Letters 532 (2002) 12^16 15
ANT-mediated uncoupling. For this reason, the lack of re-
sponse shown by ANT1 mRNA to T3 injection [21] does
not exclude the involvement of this protein in mitochondrial
T3-induced uncoupling.
In this context, we con¢rmed that gastrocnemius ANT1
mRNA is not regulated by T3; in fact, in this muscle no
changes in its level were evident whatever the thyroid state
(data not shown). Despite this, we showed that in skeletal
muscle, ANT is, to some extent, involved in the uncoupling
e¡ect of fatty acids in mitochondria and that it mediates a
part of the T3-induced uncoupling. In fact, the contribution
made by ANT to the changes in mitochondrial uncoupling
was evident only in the hyperthyroid state and then only at
the highest FFA concentration used.
We should point out that we cannot exclude a contribution
to T3-mediated FFA-dependent uncoupling by other mito-
chondrial anion carriers able to transport fatty acid anions
(glutamate/aspartate antiporter, dicarboxylate carrier and
phosphate carrier).
In conclusion, our data indicate that in the euthyroid state,
FFA in£uence UCP3 activity, which is presumably mainly
responsible for FFA-mediated uncoupling, but the ANT con-
tribution is much less a¡ected. However, in the hyperthyroid
state (in the presence of the highest concentration of FFA we
used) the ANT contribution became more relevant. On the
basis of these and previous results [2,27] we might predict a
tissue speci¢city in thyroid-hormone-induced mitochondrial
uncoupling: in the liver, the e¡ect may be principally medi-
ated by ANT2 (or another, as yet unknown, UCP), while in
skeletal muscle the e¡ect may be principally due to UCP3.
On the basis of the results reported here we can speculate
that hyperthyroid rats may be a physiological animal model
‘analogous’ to genetically manipulated UCP3-overexpressing
mice. In fact, both hyperthyroid and UCP3-overexpressing
animals show a higher level of UCP3 than normal ones.
Moreover, both have an increased metabolic rate, use lipid
as their preferential substrate and have skeletal muscle mito-
chondria that are more uncoupled than those in normal ani-
mals [5,26].
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